AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more
All-In with Chamath, Jason, Sacks & Friedberg
Biogen's Alsheimers Drug - The First New Treatment for Alseimers in Nearly Two Decades
The fda approved a new treatment for alsheimers on Monday. It does not reverse the disease's progression, but it does mitigate it against it getting worse. The drug is going to cost 55 thousand dollars and still requires brain scans. David Friedberg: Is what we're seeing in journalism and social media now happening in science? Or is this some other search for truth or some other issue?
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode